Similar articles

• Drug resistance of Mycobacterium leprae, particularly to DDS.

  Rees RJ. Rees RJ. Int J Lepr Other Mycobact Dis. 1967 Oct-Dec;35(4):625-38. Int J Lepr Other Mycobact Dis. 1967. PMID: 4173566 No abstract available.
• The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.

  Shepard CC, Levy L, Fasal P. Shepard CC, et al. Am J Trop Med Hyg. 1969 Mar;18(2):258-63. Am J Trop Med Hyg. 1969. PMID: 4888029 No abstract available.
• Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.

  Centers for Disease Control (CDC). Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep. 1982 Jan 8;30(52):637-8. MMWR Morb Mortal Wkly Rep. 1982. PMID: 6798411 No abstract available.
• Chemotherapy of leprosy.

  Shepard CC. Shepard CC. Annu Rev Pharmacol. 1969;9:37-50. doi: 10.1146/annurev.pa.09.040169.000345. Annu Rev Pharmacol. 1969. PMID: 4892433 Review. No abstract available.
• Recent advances in the study of the leprosy bacillus.

  Rees RJ. Rees RJ. Sci Basis Med Annu Rev. 1969:320-35. Sci Basis Med Annu Rev. 1969. PMID: 4917843 Review. No abstract available.